Actively Recruiting
Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.
Led by The Searle Company Limited Pakistan · Updated on 2025-05-15
420
Participants Needed
2
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The American College of Cardiology/American Heart Association hypertension guidelines recommend treatment initiation with dual antihypertensive therapy in adults with stage 2 hypertension (corresponding to grade 1 and 2 in the ESH classification) and an average BP \>20/10 mm Hg above target. Amlodipine and valsartan are two of the most commonly prescribed medications for the treatment of hypertension (high blood pressure). In Pakistan multiple studies were conducted on Hypertension and use of Single Pill Combination in uncontrolled Hypertension. However, no study was conducted to assess the role of Single Pill Combination (SPC) like Amlodipine and Valsartan in newly diagnosed hypertension and to assess their quality of life by patients' satisfaction with their medication after managing the hypertension with the SPC.
CONDITIONS
Official Title
Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with a clinical history of hypertension (systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg) and never had antihypertensive treatment
- Patient aged 18 to 70 years inclusive of either sex
- Patient with ability to understand and sign written informed consent form
You will not qualify if you...
- Patients already on antihypertensive treatment or with secondary hypertension
- Pregnant women or nursing mothers
- Patients with acute illnesses or psychiatric diagnosis
- Known hypersensitivity to Extor product, its metabolites, or formulation excipients
- Patients treated with Extor to evaluate safety as per approved prescribing information in Pakistan
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Kuwait Teaching Hospital
Peshawar, KPK, Pakistan
Actively Recruiting
2
National Medical Centre
Karachi, Pakistan
Actively Recruiting
Research Team
A
ALI Y Khanzada, MBBS, MSc
CONTACT
A
Ayesha Ashal, Doctor of Pharmacy
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here